Cargando…
The regulation of muscle mass by endogenous glucocorticoids
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inf...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315033/ https://www.ncbi.nlm.nih.gov/pubmed/25691871 http://dx.doi.org/10.3389/fphys.2015.00012 |
_version_ | 1782355413567537152 |
---|---|
author | Braun, Theodore P. Marks, Daniel L. |
author_facet | Braun, Theodore P. Marks, Daniel L. |
author_sort | Braun, Theodore P. |
collection | PubMed |
description | Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiquitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed. |
format | Online Article Text |
id | pubmed-4315033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43150332015-02-17 The regulation of muscle mass by endogenous glucocorticoids Braun, Theodore P. Marks, Daniel L. Front Physiol Physiology Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiquitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed. Frontiers Media S.A. 2015-02-03 /pmc/articles/PMC4315033/ /pubmed/25691871 http://dx.doi.org/10.3389/fphys.2015.00012 Text en Copyright © 2015 Braun and Marks. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Braun, Theodore P. Marks, Daniel L. The regulation of muscle mass by endogenous glucocorticoids |
title | The regulation of muscle mass by endogenous glucocorticoids |
title_full | The regulation of muscle mass by endogenous glucocorticoids |
title_fullStr | The regulation of muscle mass by endogenous glucocorticoids |
title_full_unstemmed | The regulation of muscle mass by endogenous glucocorticoids |
title_short | The regulation of muscle mass by endogenous glucocorticoids |
title_sort | regulation of muscle mass by endogenous glucocorticoids |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315033/ https://www.ncbi.nlm.nih.gov/pubmed/25691871 http://dx.doi.org/10.3389/fphys.2015.00012 |
work_keys_str_mv | AT brauntheodorep theregulationofmusclemassbyendogenousglucocorticoids AT marksdaniell theregulationofmusclemassbyendogenousglucocorticoids AT brauntheodorep regulationofmusclemassbyendogenousglucocorticoids AT marksdaniell regulationofmusclemassbyendogenousglucocorticoids |